INTRODUCTION
Lysophospholipid acyltransferases (LPLATs) catalyse the addition of fatty acyl moieties to the glycerol backbone of lysophospholipids [1] . In addition to playing a vital role in the synthesis of structural membrane components, the LPLATs are also implicated in cellular signalling responses for cytokines, growth factors and other agonists. For example, cellular signalling through the interleukin 1 receptor in human mesangial cells and EL-4 cells has been shown to proceed via the activation of lysophosphatidic acid acyltransferase (LPAAT) [2, 3] . The activation of LPAAT by interleukin 1 results in the generation of novel unsaturated phosphatidic acid species, which are crucial to the subsequent generation of diacylglycerol and further interleukin 1 signalling [2] . LPLATs are also implicated in the signalling for increased interleukin 2 synthesis through the antigen receptor on T-cells [4] . In this case, activation of T-cells via αCD3 stimulation has been shown to increase incorporation of polyunsaturated fatty acids into phosphatidylcholine via lysophosphatidylcholine acyltransferase. Activation of this enzyme is specifically inhibited by cyclosporin and is essential for the sustained activation and translocation of protein kinase C β. Increased lysophosphatidylcholine acyltransferase activity and phospholipid acyl group remodelling has also been implicated in interferon γ signalling in macrophages leading to hypersensitivity to endotoxin [5] [6] [7] . Although the most common route for acylation of lysophospholipids is via the CoA-dependent Lands system [1] , other pathways are also active [8] . For example, in addition to the transfer of non-esterified fatty acyl-CoA moieties to lysophospholipids, acylation of lysophospholipids can also be achieved by a CoA-independent pathway [9] , which directly transfers unsaturated fatty acid from the 2h position of 1-acylphospholipids to the 2h position of 1h-O-alkyl-and 1h-Oalkenyl-lysophospholipids. Like the CoA-dependent pathways of lysophospholipid acylation, this CoA-independent LPLAT Abbreviations used : LPLAT, lysophospholipid acyltransferase ; LPAAT, lysophosphatidic acid acyltransferase ; EST, expressed sequence tag ; dNTPs, deoxynucleotide triphosphates ; RACE, rapid amplification of cDNA ends ; IPTG, isopropyl β-D-thiogalactopyranoside ; DTNB, 5,5h-dithiobis-(2-nitrobenzoic acid) ; ORF, open reading frame ; GAPDH, glyceraldehyde-3-phosphate dehydrogenase. 1 To whom correspondence should be addressed.
blot analysis of the cDNA sequence indicated high levels of expression in immune cells and epithelium. Rapid amplification of cDNA ends revealed differentially expressed splice variants, which suggests regulation of the enzyme by alternative splicing. This cDNA therefore represents the first described sequence of a mammalian gene homologous to non-mammalian lysophosphatidic acid acyltransferases.
pathway is heavily implicated in cellular cytokine and antigen signalling for enhanced inflammatory mediator production [10, 11] . Despite the importance of LPLATs in cellular signalling events, no mammalian LPLATs have been cloned to date. However, several non-mammalian LPAAT enzymes have been cloned from E. coli, yeast and various plant species [12] [13] [14] [15] [16] [17] . In the present study we report for the first time the isolation and functional expression of a human cDNA with sequence similarity to previously cloned non-mammalian LPAATs which increases cellular LPLAT activity.
MATERIALS AND METHODS

cDNA cloning
Potential human homologues of previously cloned LPAAT genes of E. coli, yeast and various plant species [12] [13] [14] [15] [16] [17] were identified using the basic local alignment search tool [18] service at the National Center for Biotechnology Information, NIH, Bethesda, MD, U.S.A. Conserved amino acid sequences were compared with translated sequences of the expressed sequence tag (EST) database using the tblastn alignment program. Sequences of the human ESTs obtained (accession numbers T77083 and N42563) were aligned using the DNASIS program (Hitachi, Olivet, France), and oligonucleotide primers were derived from the ends of the aligned sequence. For cDNA cloning, 1 µg of total RNA from the human macrophage cell line, U937, was reverse transcribed using 2n5 units of murine leukaemia virus reverse transcriptase (GeneAmp RNA-PCR kit ; Perkin-Elmer, Foster City, CA, U.S.A.) with 2n5 µM Oligo(dT), 1 mM dNTPs, 5 mM MgCl # and 1 unit of RNase inhibitor in the supplied buffer at 42 mC for 15 min. A negative control containing no reverse transcriptase enzyme was set up in parallel. The cDNA was recovered by phenol\chloroform extraction followed by ethanol precipitation and amplified by PCR using 1 µl of Advantage Klentaq high-fidelity thermostable polymerase mix (Clontech, Palo Alto, CA, U.S.A.) with 0n2 mM dNTPs and 2 µM oligonucleotide primers (described below) in the supplied buffer. The following PCR parameters were employed : five cycles of 94 mC for 10 s, 72 mC for 3 min ; five cycles of 94 mC for 10 s, 70 mC for 3 min ; 25 cycles of 94 mC for 10 s, 68 mC for 4 min ; a final incubation at 72 mC for 7 min. Amplified cDNA was cloned into the vector, pCR2.1 (TA Cloning Kit ; Invitrogen, San Diego, CA, U.S.A.), for sequencing, and inserts matching the original EST sequences were subcloned into the expression vector, pBK-CMV (Stratagene, La Jolla, CA, U.S.A.). The wild-type E. coli LPAAT gene [10] was similarly amplified from E. coli strain XL2Blue MRFh (Stratagene), sequenced and subcloned into pBK-CMV. 5h and 3h rapid amplification of cDNA ends (RACE) [19] were carried out using human peripheral blood leucocyte cDNA as template (Marathon-Ready cDNA ; Clontech), using the supplier's recommended protocol and the PCR conditions described above. Sequencing was performed on an ABI 310 automated sequencer using dye terminators (Perkin-Elmer Applied Biosystems Division) with a minimum of three passes on each strand.
Oligonucleotides
For the initial cDNA cloning. oligonucleotide sequences were derived from the ends of the aligned ESTs : 5h-CTTCTACAAT-GGCTGGATCC and 5h-CAACTGTCCCACAGACAAGA. For cloning the full-length sequence obtained by 5h RACE, the first of these primers was replaced by the following sequence : 5h-GTGGCCAGAATGGATTTGTG. The E. coli LPAAT gene was amplified using the oligonucleotides : 5h-GTATTCAACCC-CCGGAAACG and 5h-CCGTGCAGGAAAGTGTTCCCC-GC.
Northern-blot hybridization
Total RNA was extracted by lysing 2i10' cells in 2 ml of RNASTAT-60 (Biogenesis Ltd., Poole, Dorset, U.K.). Chloroform (0n4 ml) was added to the lysate and RNA precipitated from the aqueous phase by the addition of 1 vol. of propan-2-ol. RNA was recovered by centrifugation and washed in 80 % (v\v) ethanol. Resuspended RNA (5 µg) was incubated for 1 h at 50 mC in 1 M deionized glyoxal\10 mM sodium phosphate (pH 7n0)\50 % (v\v) DMSO, then separated on a 1 % (w\v) agarose gel in 10 mM sodium phosphate, pH 7n0, electrophoresis buffer at 40 V with buffer recirculation. The gel was treated for 20 min with 50 mM NaOH\100 mM NaCl, followed by 20 min in 100 mM Tris\HCl, pH 7n6, then 20 min in 2iSSC (1iSSC l 0n15 M NaCl\0n015 M sodium citrate). The RNA was transferred to Zetaprobe membrane (Bio-Rad Laboratories, Hercules, CA, U.S.A.) in 20iSSC, and cross-linked to the membrane by baking at 80 mC for 2 h. DNA probes were labelled with [α-$#P]dCTP using a RediPrime kit (Amersham International, Amersham, Bucks., U.K.), denatured and hybridized to Northern blots by standard techniques [20] . For the human LPAAT homologue, the partial cDNA probe was isolated from a pCR2.1 construct by EcoRI restriction digestion and preparative agarosegel separation. A glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA probe was used to confirm similar RNA loading of each lane of the Northern blots.
Cellular expression
JC201, a LPAAT-deficient E. coli strain that is temperaturesensitive for growth at 37 mC [21] , was transformed with the expression constructs described. Expression was induced in bacteria by addition of 2 mM isopropyl β--thiogalactoside (IPTG) to a 5 ml culture in L-Broth containing 50 µg\ml kanamycin sulphate (Sigma, Poole, Dorset, U.K.) at A '!! l 1n0, followed by incubation at 37 mC for 2 h. Complementation studies were carried out by plating transformations on L-agar containing 2 mM IPTG plus 50 µg\ml kanamycin sulphate. Duplicate plates were incubated overnight at either 30 or 37 mC. Mammalian COS7 cells were transfected with the same plasmids using a standard lipofection technique (DMRIE-C ; Gibco, Paisley, Scotland, U.K.). Stable transfected COS7 cell lines were obtained by selection in 2 mg\ml G418 (Sigma). COS7 cells were routinely maintained in Dulbecco's modified Eagle's medium plus 10 % fetal calf serum (Gibco) to confluence and passaged with trypsin\EDTA (Gibco) at 1 : 10 ratios.
Lipid analysis
Bacterial cultures were induced with IPTG and labelled with 1n0 µCi of [$H]oleic acid for 30 min. Total cellular lipids were extracted into chloroform\methanol by the protocol of Bligh and Dyer [22] . Lipids in the chloroform layer were dried under vacuum, resuspended in 200 µl of chloroform and analysed by normal) phase HPLC on a 3 mm Spherisorb column (0n5 cmi 25 cm) using a gradient of 1-9 % water in hexane\propan-2-ol (3 : 4, v\v), [2] . Incorporated radioactivity was detected with an in-line radiochemical detector (Canberra Packard, Pangbourne, Kent, U.K.).
Enzyme assay
CoA-dependent acyltransferase activity of COS7 cell membranes was determined colorimetrically using the 5,5h-dithiobis-(2-nitrobenzoic acid) (DTNB) reaction [23] . Briefly, cells were disrupted by sonication, centrifuged at 500 g and membranes prepared from the resulting supernatant by centrifugation at 100 000 g for 1 h. Incubations contained 0n5 mM DTNB, 0n5 mM lysophosphatidic acid and 0n1 mM acyl CoA in a final volume of 200 µl. Reaction was started by the addition of 5 µg of membranes and the increase in A %!& continuously monitored for 5 min using an MDC 96-well plate reader. V max values were calculated as µmol\min per µg of protein using a molar absorption coefficient for DTNB of 14 800.
RESULTS
Identification and cloning of a human LPAAT homologue
On the basis of the conserved amino acid sequences of known LPAAT genes from E. coli [12] , Saccharomyces cere isiae [13] and a number of plant species [14] [15] [16] [17] , we obtained EST data on a potential human homologue (GenBank accession nos. T77083 and N42563). These overlapping clones encoded not only the conserved codons used for their identification but also further homologies to known LPAAT proteins (Figure 1 ). Oligonucleotide primers directed to the ends of the aligned sequence were used to amplify the sequence from U937 cell cDNA as described in the Materials and methods section. A 1045 bp fragment was obtained containing a sequence that matched that of the original aligned ESTs. Sequencing of 11 different clones obtained from five separate PCR amplifications, which used a thermostable polymerase mix containing a proofreading enzyme activity, revealed no sequence variation in the 224-codon major open reading frame (ORF) encoded by the U937 sequence (Figure 2) . The translated amino acid sequence contained all of the previously identified LPAAT homologies [14] . We have extended
Figure 1 Sequence alignment of U937 cDNA translation with the homologous regions of known LPAAT proteins
Regions of highest homology are indicated by bold lines. Previously identified LPAAT conserved regions [14] are numbered. Conserved residues are identified by darker shading, and semiconserved residues by lighter shading. L. douglassi, Limnanthes douglasii ; C. nucifera, Cacos nucifera ; Z. mays, Zea mays.
these homologies and identified a further homologous sequence from the C-terminal region (Figure 1 ).
Identification of a splice variant by 5h RACE
Northern-blot hybridization of the cDNA sequence produced a strong signal in a variety of tissues (Figure 3) , showing relative abundance of expression in immune cells and epithelium. On longer exposures, a number of minor bands also appeared, suggesting the presence of related sequences. The major band migrated at approx 2 kb, indicating that the hybridizing sequence represented a partial clone. Sequences from the 5h and 3h termini of the mRNA were therefore obtained by RACE [19] . A further 800 nt were obtained downstream of the core sequence, including a potential polyadenylation signal 9 nt upstream of a polydeoxyadenosine tract (Figure 2) . 5h RACE obtained a further 125 nt of sequence. Analysis of a number of 5h RACE products also revealed that the mRNA was differentially spliced at nt 210 (Figure 2) . Some 47 nt of sequence downstream of this point, which was present in the original EST alignment and in the U937 partial cDNA clone (above), was absent from the majority of clones obtained by 5h RACE. The presence of a canonical splice junction (AAGA) at this position suggested that the 47 nt sequence represented a differentially spliced exon, which we designated exon C (Figure 2 ). The total length of cDNA sequence obtained by these methods was 1970 nt which agreed with the Northern-blot hybridization data (Figure 3) . Reverse transcriptase-PCR amplification of U937 cell mRNA, using primers corresponding to the ends of the 5h and 3h RACE sequences, produced approx. 2 kb cDNA fragments with the sequence shown in Figure 2 .
Extended ORF encoded by splice variant
Computerized translation of the full-length sequences obtained by RACE revealed that differential splicing of exon C affected the potential coding region. Whereas the LPAAT-homologous sequences remained unchanged, the presence or absence of exon
Figure 2 Sequence analysis of novel U937 cDNA
The sequence of the full-length cDNA cloned from U937 cells is shown. This sequence is stored in the GenBank database under accession number U75971. The initially cloned U937 partial cDNA sequence based on GenBank ESTs T77083 and N42563 is shown in bold (nt 126-1170). This sequence was used as a probe for Northern-blot hybridization (Figure 3) . The LPAAT conserved amino acids are encoded between nt 362 and nt 780. Potential initiator methionine codons are boxed. ORF1 is contiguous with the conserved region via the differentially spliced exon C (horizontal line). When exon C is spliced out, ORF2 is juxtaposed with the conserved amino acids, providing an alternative N-terminus to this conserved domain.
Figure 3 Northern-blot hybridization of human LPAAT homologous sequence
The 1045 bp partial cDNA fragment containing the core LPAAT homologous region (nt 126-1170, Figure 2) C linked this conserved region to ORF1 or ORF2 respectively ( Figure 2 ). The first methionine codon of ORF1 was situated downstream of that of ORF2. ORF1 was contiguous with the conserved region only in the relatively rare cDNAs that contained exon C, creating an extended ORF of 292 codons. It is unlikely therefore that ORF1 could be substantially expressed at the protein level in U937 cells. However, in the major cDNA product, ORF2 was spliced to the LPAAT homologous core region, encoding a 282-amino-acid ORF. The extended N-terminus was characterized by a high proportion of hydrophobic residues (Figure 2) , suggesting a possible mechanism for membrane targeting. Although the apparently short 5h untranslated region might indicate that further 5h mRNA sequences remain to be discovered, the present evidence suggests that ORF2 is the fulllength coding sequence. First, the total length of cDNA cloned correlated well with Northern-blot hybridization data. The potential molecular mass of the encoded protein (" 28 kDa) is similar to that of an acyltransferase protein isolated from rat liver microsomes [24] . A recently sequenced LPAAT homologue of Caenorhabditis elegans (GenBank accession number Z73975) encodes a similar leucine-rich N-terminus. Finally, the first methionine codon of ORF2 is in a highly favourable sequence context for translation initiation. We therefore proceeded to express ORF2 in prokaryotic and mammalian cells in order to study its biological activity.
Expression in E. coli affects membrane lipid profile
In order to study the biological activity of the human sequence, a plasmid expression construct, U3, was prepared by PCR amplification of nt 1-1170 (Figure 2 ) from U937 cDNA followed by cloning into the vector pBK-CMV, enabling both prokaryotic and eukaryotic expression of the full-length ORF2. E. coli strain JC201, which has a temperature-sensitive lesion resulting from a defective LPAAT gene, was transformed with U3 or vector alone. Transformants were grown at the permissive temperature (30 mC), and protein expression was induced with IPTG at 37 mC, as described in the Materials and methods section. Bacterial cultures were normalized to A '!! l 1n0 before the addition of 1n0 µCi of [$H]oleic acid for 30 min. Oleic acid was incorporated predominantly into peaks corresponding to phosphatidylethanolamine and phosphatidylglycerol standards, with minor amounts 
Figure 4 Quantification of mRNA expression in transfected COS7 cell lines
Total RNA (5 µg) from stable transfectant COS7 cell lines containing vector only (C) or the U937 cDNA construct (U3) was separated on a 1 % agarose gel and transferred to nylon membrane as described in the Materials and methods section. The 1045 bp partial cDNA fragment containing the core LPAAT homologous region (nt 126-1170, Figure 2 ) was labelled with 32 P and hybridized to the blot. The blot was subsequently hybridized to a GAPDH probe. Hybridization signals were measured directly from the blot by linear quantification on a Canberra Packard Instant Imager. Accumulated counts from each band are shown below autoradiographs of the same hybridizations. The top panel was obtained with the cDNA probe, with GAPDH bands shown beneath.
being found in the neutral diacylglycerol and triacylglycerol lipid fraction. In comparison with the wild-type JC200 strain, the LPAAT-defective JC201 strain incorporated markedly less oleic acid into the membrane phospholipids ( Table 1 ). The deficiency in oleic acid incorporation was corrected by expression of the wild-type E. coli LPAAT gene. In addition, expression of the mammalian homologue of E. coli LPAAT, U3, also significantly increased incorporation of oleic acid into membrane phospholipids in the LPAAT-deficient JC201 strain (Table 1 ). This suggests that the mammalian homologue U3 encodes a protein exhibiting LPAAT activity similar to that of the wild-type E. coli LPAAT, in the LPAAT-deficient JC201 strain. Transformation of JC201 with the wild-type E. coli LPAAT gene complemented the temperature-sensitive defect, resulting in growth of similar numbers of colonies on duplicate plates at both permissive and non-permissive temperatures. However, reproducible growth of transformed JC201 cells at the nonpermissive temperature was not observed with the mammalian LPAAT constructs, even after IPTG induction, i.e. under conditions that partially corrected the fatty acid-incorporation defect (Table 1) .
Acyltransferase activity of conserved amino acid sequences in COS7 cells
COS7 cells were transfected with U3 or empty vector and selected by G418 resistance to derive stable cell transfectants. Northern-blot analysis of the stable cell lines showed only a singlefold increase in expression of the human cDNA above the endogenous gene (Figure 4) , indicating a probable selection pressure against high expression in stable cell lines. Membranes prepared from cDNA transfectants and controls were assayed for CoA-dependent acyltransferase activity using a range of fatty acyl-CoA donors and lysophosphatidic acid as acceptor. The results (Table 2) indicate that expression of the mammalian cDNA sequence significantly increases LPAAT activity of COS7 membranes, with an apparent preference for C ") : " monounsaturated CoA as acyl donor.
DISCUSSION
We have identified a human gene sequence containing major similarities to the conserved regions of LPAAT genes of various highly diverse organisms. Expression of this mammalian LPAAT homologue increases fatty acid incorporation into membrane phospholipids in prokaryotic cells (Table 1) , and stable expression in COS7 cells increases the specific activity of membrane LPAAT (Table 2 ). These data, together with the identification of alternatively spliced forms of the core sequence (Figure 2) , strongly suggest that the novel mammalian gene sequences encode a family of proteins that play a major role in phospholipid turnover. Whereas expression of the human LPAAT homologue in LPAAT-deficient E. coli strain JC201 dramatically increased fatty acid incorporation into membrane phospholipids (Table 1) , reproducible complementation of the temperature-sensitive lesion was not obtained. Transformation of JC201 with the wildtype E. coli LPAAT both restored phospholipid acylation with oleic acid and enabled growth at the non-permissive temperature. The reasons for the failure of the human LPAAT homologue to complement despite the ability to increase oleic acid acylation are at present unclear but could relate to differences in acyl donor substrate specificity between eukaryotic and prokaryotic forms of the gene. It is possible that the restricted acyl donor specificity of the mammalian homologue is not sufficient to enable growth at the non-permissive temperature. For the mammalian LPAAT homologue, although a preference for unsaturated fatty acyl donors to lysophosphatidic acid is suggested by the enzyme activity data shown in Table 2 , many other factors are likely to play an important role in determining specific activity, substrate selectivity and function of the conserved sequences. Our further investigations have shown that the 5h end of the conserved LPAAT mRNA can be altered by differential splicing, enabling the attachment of two different N-termini to the conserved core region (Figure 2) . The hydrophobic nature of these N-termini suggests a mechanism for membrane insertion that will undoubtedly influence the activity of the core sequence in E. coli and COS7 cell membranes. Furthermore changes in substrate specificity for both donor acyl-CoA and acceptor lysophospholipid can be expected to arise as a result of the alternative splicing. It is also likely that the hydrophobic alternative leader sequences may also target the protein to different cellular sites. All of these factors will therefore impinge on the final specific activity and substrate selectivity of the expressed sequence. Further work is already going on to identify the functional consequences of alternative splicing of the conserved LPAAT core sequence.
The proximity of the initiator codon to the 5h end of the U937 cDNA ( Figure 2 ) suggests that the cDNA may not be full length. However, the translationally favourable context of this methionine codon and homology to an LPAAT homologue of C. elegans suggests that this is the likely translational initiator of the ORF.
The human LPAAT homologue was found to be expressed at high levels in a variety of tissues (Figure 3 ). Although this might be taken to indicate that the gene encodes a housekeeping activity, differential splicing and other possible translational controls, as well as changes in the hydrophobic leader sequences, strongly suggest that the products of this single gene may vary in their specificity, cellular localization and level of expression. Nevertheless, a singlefold increase in U3 mRNA expression (Figure 4 ) gave up to a 75 % increase in acyltransferase activity with respect to oleoyl-CoA ( Table 2 ), suggesting that the protein product of the U3 transcript plays a major part in membrane fatty acyl incorporation.
In conclusion, these results describe a human gene with homologies to non-mammalian LPAAT sequences. Expression of the gene causes an increase in fatty acyl incorporation in both E. coli and COS7 membrane phospholipids and represents the first description of what is probably a family of mammalian genes involved in phospholipid regulation, with important functions in homoeostasis and cell signalling.
